Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing, and pathological evaluation. The platform can assist in connecting national and international teams of authoritative experts to provide accurate diagnostics and treatment programs. Treatment and management of the treatment complexes in developing countries require multi-dimensional management, typically including drug therapy, rehabilitation interventions, and regular follow-up.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult-to-treat blood tumour diseases have been significantly improved. Treatment requires close monitoring of efficacy and adverse reactions and timely adjustment to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of HL in developing countries.
The platform serves the China International Medical Service System, a team of domestic and foreign experts with authority in the field of blood tumours, who provide the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.